LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Y39983 | 3.33 | uM | LJP6 | 3 | P02 | 72 | hr | 765 | 2044 | 3066 | 0.6667 | 0.6334 |
Hs 578T | Y39983 | 10 | uM | LJP6 | 1 | P01 | 72 | hr | 765 | 664 | 3143 | 0.2112 | -0.0671 |
Hs 578T | Y39983 | 10 | uM | LJP6 | 2 | P01 | 72 | hr | 765 | 786 | 3095 | 0.2539 | 0.0135 |
Hs 578T | Y39983 | 10 | uM | LJP6 | 3 | P01 | 72 | hr | 765 | 771 | 3066 | 0.2515 | 0.0039 |
Hs 578T | Nintedanib | 0.04 | uM | LJP6 | 1 | H06 | 72 | hr | 765 | 2869 | 3143 | 0.9126 | 0.9123 |
Hs 578T | Nintedanib | 0.04 | uM | LJP6 | 2 | H06 | 72 | hr | 765 | 2775 | 3095 | 0.8964 | 0.8944 |
Hs 578T | Nintedanib | 0.04 | uM | LJP6 | 3 | H06 | 72 | hr | 765 | 2804 | 3066 | 0.9146 | 0.9128 |
Hs 578T | Nintedanib | 0.12 | uM | LJP6 | 1 | H05 | 72 | hr | 765 | 2716 | 3143 | 0.8639 | 0.8616 |
Hs 578T | Nintedanib | 0.12 | uM | LJP6 | 2 | H05 | 72 | hr | 765 | 2692 | 3095 | 0.8696 | 0.8661 |
Hs 578T | Nintedanib | 0.12 | uM | LJP6 | 3 | H05 | 72 | hr | 765 | 2597 | 3066 | 0.8470 | 0.8409 |
Hs 578T | Nintedanib | 0.37 | uM | LJP6 | 1 | H04 | 72 | hr | 765 | 2328 | 3143 | 0.7405 | 0.7260 |
Hs 578T | Nintedanib | 0.37 | uM | LJP6 | 2 | H04 | 72 | hr | 765 | 2246 | 3095 | 0.7255 | 0.7058 |
Hs 578T | Nintedanib | 0.37 | uM | LJP6 | 3 | H04 | 72 | hr | 765 | 2281 | 3066 | 0.7440 | 0.7254 |
Hs 578T | Nintedanib | 1.11 | uM | LJP6 | 1 | H03 | 72 | hr | 765 | 2192 | 3143 | 0.6973 | 0.6758 |
Hs 578T | Nintedanib | 1.11 | uM | LJP6 | 2 | H03 | 72 | hr | 765 | 2218 | 3095 | 0.7165 | 0.6952 |
Hs 578T | Nintedanib | 1.11 | uM | LJP6 | 3 | H03 | 72 | hr | 765 | 2131 | 3066 | 0.6950 | 0.6678 |
Hs 578T | Nintedanib | 3.33 | uM | LJP6 | 1 | H02 | 72 | hr | 765 | 1211 | 3143 | 0.3852 | 0.2526 |
Hs 578T | Nintedanib | 3.33 | uM | LJP6 | 2 | H02 | 72 | hr | 765 | 1734 | 3095 | 0.5601 | 0.5004 |
Hs 578T | Nintedanib | 3.33 | uM | LJP6 | 3 | H02 | 72 | hr | 765 | 1859 | 3066 | 0.6063 | 0.5579 |
Hs 578T | Nintedanib | 10 | uM | LJP6 | 1 | H01 | 72 | hr | 765 | 1291 | 3143 | 0.4107 | 0.2926 |
Hs 578T | Nintedanib | 10 | uM | LJP6 | 2 | H01 | 72 | hr | 765 | 1185 | 3095 | 0.3828 | 0.2423 |
Hs 578T | Nintedanib | 10 | uM | LJP6 | 3 | H01 | 72 | hr | 765 | 1029 | 3066 | 0.3356 | 0.1595 |
Hs 578T | Foretinib | 0.04 | uM | LJP5 | 1 | H12 | 72 | hr | 765 | 2849 | 3140 | 0.9072 | 0.9067 |
Hs 578T | Foretinib | 0.04 | uM | LJP5 | 2 | H12 | 72 | hr | 765 | 2794 | 3151 | 0.8865 | 0.8855 |
Hs 578T | Foretinib | 0.04 | uM | LJP5 | 3 | H12 | 72 | hr | 765 | 2783 | 3152 | 0.8828 | 0.8816 |